Oneirogen reviews / all compounds
Fourteen compounds, one variable at a time, fixed dose and fixed timing. Five coincided with a lucid dream. Five did nothing measurable at all. Here is the whole record, including the failures.
Most of what gets sold or recommended for lucid dreaming did nothing for us. That is the least marketable sentence on this site and it is the most useful one.
Across fourteen compounds, five produced no detectable change on any measure we track. Most of the remainder produced small shifts in recall or vividness that could plausibly be noise. One, galantamine, produced something that looked like an actual effect.
These are oneirogen reviews in the plainest sense: one compound at a time, a fixed protocol, and a written record of what changed and what did not.
One compound at a time. No stacking, no behavioural techniques layered on top, no dream journaling introduced unless journaling is the thing being tested. Protocols run at least seven consecutive nights at a fixed dose and fixed timing, with a washout when it is relevant.
That restraint is the point. Dreams vary wildly night to night, so a single good night proves close to nothing, and any protocol that changes three things at once cannot tell you which one mattered.
Galantamine, 8 mg, wake-back-to-bed. Three lucid dreams in fourteen nights, clustered on nights five through seven. The strongest signal in the matrix and the only compound with a high impact rating.
Silene capensis, foam, morning, empty stomach. Two lucid dreams back to back on nights six and seven of a fourteen night run, including a dream within a dream. Control conditions were unstable during that stretch, so the attribution is weaker than the count suggests.
Calea zacatechichi. One lucid dream, on night nineteen of an extended run.
Mugwort, 2 g tea, pre-bed. One lucid dream on a night where the protocol was already compromised. It counts in the ledger as an event and it is suggestive rather than attributable.
Vitamin B6, 240 mg. One lucid dream on the final night of a seven night run. Unresolved, and not claimed as causal.
Five compounds came back null: blue lotus at 5 g including a double dose attempt, African fever tree at 2 g, alpha-GPC at 600 mg on wake-back-to-bed timing, Mexican tarragon, and L-DOPA.
Alpha-GPC is the interesting failure. It raises acetylcholine availability, which is the same broad mechanism galantamine is supposed to work through, and it was dosed on the same schedule. It produced nothing. Huperzine A, another cholinesterase inhibitor, produced no lucidity either across 200 and 400 mcg. If the acetylcholine story were the whole explanation, that family should behave more alike than it does.
Synaptolepis kirkii, Celastrus paniculatus, and wild lettuce all produced low impact results: some movement in recall or sleep quality, nothing that separated cleanly from an ordinary week.
Two lucid dreams occurred before any testing began, so a nonzero baseline exists. The runs are unblinded and there is no placebo arm, which matters more here than in most self-experiments, because expectancy and simple attention to sleep are themselves known to raise lucid dream frequency.
Everyone in these results is the same person, which means every number carries that person's sleep, stress, and caffeine habits with it. Read the matrix as a structured record of what happened, not as a ranking of what works.
More people running the same protocol at the same time, with a baseline week logged the same way. That is what the group tests are for, and the first one is open now.
Not medical advice. Nightcone documents self-experimentation for research interest. Compounds discussed can carry real toxicity and interaction risks.
Results from controlled oneirogen experiments. What impacted dreaming, what didn't, and topical news. New tests each cycle.